Transpek Industry Limited Reports Q3FY26 Financial Results with Steady Performance

2 min read     Updated on 18 Feb 2026, 03:24 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Transpek Industry Limited reported Q3FY26 revenue of Rs 158.5 crores with improved EBITDA margin of 17.6%. Nine-month results showed revenue of Rs 473.0 crores with significant PAT growth of 32.5% to Rs 39.1 crores. The company received EcoVadis Gold Award for sustainability performance and multiple industry recognitions during the period.

32954043

*this image is generated using AI for illustrative purposes only.

Transpek Industry Limited has announced its financial results for the third quarter and nine months of FY26, demonstrating resilient performance amid market conditions. The specialty chemicals manufacturer, known for its chlorinated products across pharmaceutical, agrochemical, and specialty chemical sectors, continues to maintain its market position through diversified operations.

Q3FY26 Financial Performance

The company's third quarter performance showed revenue moderation compared to the previous year, with total revenue including other income reaching Rs 162.0 crores against Rs 174.9 crores in Q3FY25.

Metric Q3 FY26 Q3 FY25 Change (%)
Revenue from Operations Rs 158.5 Cr Rs 170.0 Cr -6.8%
EBITDA Rs 28.5 Cr Rs 28.8 Cr -1.3%
EBITDA Margin 17.6% 16.5% +110 bps
PAT Rs 10.8 Cr Rs 10.6 Cr +1.9%
PAT Margin 6.7% 6.1% +60 bps
EPS Rs 19.42 Rs 19.06 +1.9%

Despite the revenue decline, the company maintained profitability with improved margins, indicating effective cost management and operational efficiency.

Nine Months FY26 Results

For the nine-month period, Transpek Industry demonstrated stronger profitability metrics with enhanced margin performance across key parameters.

Metric 9M FY26 9M FY25 Change (%)
Revenue from Operations Rs 473.0 Cr Rs 484.6 Cr -2.4%
EBITDA Rs 95.9 Cr Rs 83.4 Cr +14.9%
EBITDA Margin 19.4% 16.5% +290 bps
PAT Rs 39.1 Cr Rs 29.5 Cr +32.5%
PAT Margin 7.9% 5.8% +210 bps
EPS Rs 69.94 Rs 52.79 +32.5%

The nine-month results reflect significant improvement in profitability metrics, with PAT growing by 32.5% despite marginal revenue decline.

Sustainability Recognition and Awards

Transpek Industry received notable recognition for its sustainability initiatives during the period. The company was awarded the prestigious EcoVadis Gold Medal for outstanding sustainability performance, ranking among the top 5% of companies evaluated by EcoVadis in the Chemical Sector. The recognition covers excellence in Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.

Additionally, the company received multiple awards including:

  • CSR Award (Large Scale Category) at the 4th GEO Excellence Awards
  • Vadodara Industrial Gaurav Award for "Industry Working for Nation Building"
  • Two awards at FICCI Chemical & Petrochemical Awards 2025: Leader in Water Management and Sustainability Leader of the Year
  • Parul University CSR Awards 2025 for best practices in Corporate Social Responsibility

Business Segments and Operations

The company's sales distribution across applications shows diversified exposure to multiple end-user industries including polymers, pharmaceuticals, specialty chemicals, agrochemicals, cosmetics, and dyes. This diversification strategy helps maintain stability across different market cycles.

Transpek Industry operates through multipurpose and multiproduct plants spread over 100 acres with total production capacity of 66,000 MTPA. The company maintains strong international presence across 16 countries, serving leading global chemical companies through long-term supply agreements.

Historical Stock Returns for Transpek Industry

1 Day5 Days1 Month6 Months1 Year5 Years
+1.75%+1.68%-0.81%-15.87%-14.49%-15.00%

Transpek Industry Q3 Results Show Improved EBITDA Performance Despite Revenue Decline

1 min read     Updated on 04 Feb 2026, 07:45 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Transpek Industry delivered mixed Q3 results with improved operational efficiency metrics including EBITDA growth to ₹249 million and margin expansion to 15.74%, alongside marginal net profit increase to ₹108 million, though revenue declined to ₹1.58 billion from ₹1.70 billion year-over-year.

31760108

*this image is generated using AI for illustrative purposes only.

Transpek Industry has delivered mixed financial results for Q3, demonstrating resilience in profitability and operational efficiency despite facing revenue headwinds. The pharmaceutical and chemical company's latest quarterly performance reflects improved margin management in a complex operating environment.

Financial Performance Overview

The company's Q3 financial metrics present a comprehensive picture of operational performance across key indicators:

Metric Q3 Current Year Q3 Previous Year Change
Standalone Net Profit ₹108 million ₹106 million +₹2 million
Revenue ₹1.58 billion ₹1.70 billion -₹0.12 billion
EBITDA ₹249 million ₹240 million +₹9 million
EBITDA Margin 15.74% 14.08% +1.66%

EBITDA and Margin Performance

Transpek Industry achieved notable improvement in its EBITDA performance during Q3, with earnings reaching ₹249 million compared to ₹240 million in the corresponding quarter of the previous year. This represents a year-over-year increase of ₹9 million, highlighting the company's enhanced operational efficiency.

The EBITDA margin expansion stands out as a key performance indicator, improving to 15.74% in Q3 from 14.08% in the same quarter last year. This 1.66 percentage point improvement demonstrates the company's successful cost optimization and operational leverage strategies.

Profitability Analysis

The company managed to achieve a marginal improvement in standalone net profit, reaching ₹108 million in Q3 compared to ₹106 million in the corresponding quarter of the previous year. This represents a year-over-year increase of ₹2 million, demonstrating sustained profitability levels despite operational challenges.

Revenue Performance

The company's revenue performance showed a contrasting trend, with Q3 revenue declining to ₹1.58 billion from ₹1.70 billion recorded in the same quarter last year. This represents a decrease of ₹0.12 billion year-over-year, indicating pressure on the company's top-line growth during the quarter.

Operational Efficiency Highlights

The Q3 results underscore Transpek Industry's operational resilience, where the company has successfully improved both EBITDA and margins while managing revenue challenges. The ability to increase net profit and expand EBITDA margins despite lower revenue reflects effective cost management and operational efficiency measures implemented during the quarter.

Historical Stock Returns for Transpek Industry

1 Day5 Days1 Month6 Months1 Year5 Years
+1.75%+1.68%-0.81%-15.87%-14.49%-15.00%

More News on Transpek Industry

1 Year Returns:-14.49%